Recent Annual Filings for MRNA

Fiscal Year Assets Revenues Costs & Expenses Comprehensive Income Cash Flow - Operating Cash Flow - Financing Total Net Cash Flow
2024 $14,142,000,000 $3,236,000,000 $7,181,000,000 $-3,448,000,000 $-3,004,000,000 $56,000,000 $-999,000,000
2023 $18,426,000,000 $6,848,000,000 $11,087,000,000 $-4,467,000,000 $-3,118,000,000 $-1,377,000,000 $-289,000,000
2022 $25,858,000,000 $19,263,000,000 $9,843,000,000 $8,016,000,000 $4,981,000,000 $-3,448,000,000 $-3,643,000,000
2021 $24,669,000,000 $18,471,000,000 $5,175,000,000 $12,175,000,000 $13,620,000,000 $-873,000,000 $4,224,000,000
2020 $7,336,750,000 $803,395,000 $1,566,539,000 $-745,864,000 $2,026,971,000 $2,033,193,000 $2,388,236,000
2019 $1,589,422,000 $60,209,000 $574,925,000 $-510,897,000 $-458,968,000 $51,121,000 $-422,792,000
2018 $1,962,149,000 $135,068,000 $519,476,000 $-384,897,000 $-330,865,000 $1,226,842,000 $523,505,000